BATS BZX Real-Time Price
As of 10:38am ET
| +0.16 / +6.56%|
The 6 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +188.46% increase from the last price of 2.60.
The current consensus among 6 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.